GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $228,000 | 0.0% | 5,177 | 0.0% | 0.26% | +25.2% |
Q1 2022 | $228,000 | +9.1% | 5,177 | +10.7% | 0.21% | +17.0% |
Q4 2021 | $209,000 | +4.0% | 4,677 | -9.7% | 0.18% | -5.4% |
Q3 2021 | $201,000 | -3.8% | 5,177 | 0.0% | 0.19% | -3.6% |
Q2 2021 | $209,000 | -7.9% | 5,177 | -5.5% | 0.19% | -33.4% |
Q2 2020 | $227,000 | +11.8% | 5,477 | +3.8% | 0.29% | -5.2% |
Q1 2020 | $203,000 | -12.1% | 5,277 | +8.4% | 0.31% | +22.4% |
Q4 2019 | $231,000 | – | 4,867 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |